QTIHIGH SIGNALREGULATORY10-K

QTI's stock was delisted from Nasdaq and moved to OTC trading, while the company shows meaningful operational improvement with substantially reduced operating losses.

The delisting from Nasdaq to OTC markets significantly impairs the company's ability to raise capital and reduces stock liquidity, creating ongoing financing challenges. However, the removal of delisting language from risk factors and substantial improvement in operating performance suggests management may be stabilizing operations and potentially positioning for future re-listing.

Comparing 2026-03-25 vs 2025-03-31View on EDGAR →
FINANCIAL ANALYSIS

QTI demonstrated meaningful operational improvement with operating losses substantially reduced and SG&A expenses declining 21%. The company increased inventory investment by 60% while reducing current liabilities by nearly 20%, suggesting better working capital management. Operating cash flow losses modestly improved, indicating the company is making progress toward operational sustainability despite the regulatory headwinds from the Nasdaq delisting.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+63.6%
-$12.2M-$4.4M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Inventory
Balance Sheet
+60.1%
$3.1M$5.0M

Inventory surged 60.1% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.

Capital Expenditure
Cash Flow
+41.2%
$88K$124K

Capital expenditure jumped 41.2% — major investment cycle underway; assess returns on deployment.

SG&A Expense
P&L
-21.3%
$11.5M$9.1M

SG&A reduced 21.3% — improved cost efficiency or headcount reduction improving operating margins.

R&D Expense
P&L
+20.5%
$3.3M$3.9M

R&D investment increased 20.5% — signals commitment to future product development, though near-term margin impact.

Current Liabilities
Balance Sheet
-19.7%
$9.8M$7.9M

Current liabilities reduced — improved short-term financial position and working capital health.

Operating Cash Flow
Cash Flow
+10.7%
-$10.0M-$9.0M

Operating cash flow grew 10.7% — strong conversion of earnings to cash, healthy business fundamentals.

LANGUAGE CHANGES
NEW — 2026-03-25
PRIOR — 2025-03-31
ADDED
SUMMARY OF RISK FACTORS The below summary of risk factors provides an overview of many of the risks we are exposed to in the normal course of our business activities.
( GigCapital5 ), our legal predecessor company and a special purpose acquisition company which was incorporated in Delaware in 2021, entered into the Business Combination Agreement with its wholly owned subsidiary, QTI Merger Sub, Inc.
When the transactions contemplated by the Business Combination Agreement (the Business Combination ) closed on March 4, 2024, Merger Sub merged with and into QT Imaging, Inc.
On that date, QT Ultrasound changed its name from QT Ultrasound LLC to QT Imaging, Inc.
National Institutes of Health has developed a novel, comprehensive body imaging technology designed to produce high-resolution volumetric images of breast tissue using low-energy transmitted sound.
+7 more — sign up free →
REMOVED
(the Company ) has received written notice from The Nasdaq Stock Market LLC ( Nasdaq ) that it has commenced proceedings to delist the Company s common (ticker symbol: QTI) from Nasdaq, and suspended trading in the Company s common stock pending the completion of such proceedings.
As a result, effective January 28, 2025, the Company s common stock commenced trading in the over the-counter market under the symbol QTIH , and the trading of the common stock was upgraded to the OTCQB Venture Market on March 11, 2025.
27,653,210 shares of common stock were outstanding at March 28, 2025.
(the Company ), as well as the Company s strategy, future operations, financial position, estimated revenues, and losses, projected costs, prospects, plans and objectives of management are forward-looking statements.
Our common stock will no longer be listed on the Nasdaq Global Market which may adversely affect our ability to raise additional financing through the public or private sale of equity securities, the ability of investors to trade our securities and the value and liquidity of our common stock.
+7 more — sign up free →
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →